In mice, an approach that blocks inflammation extends organ survival from about a week to more than two months A new study by scientists at Cincinnati Children's Hospital shows there …
Tag:
antibody
-
-
Bone marrow transplantion
Tonix Pharmaceuticals completes Phase 1 clinical trial of TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody) in healthy volunteers
Tonix Pharmaceuticals Holding Co., Ltd. Top-line results are expected in the third quarter of 2024.Planning phase 2 trial to prevent kidney transplant rejection Anti-CD40L has multiple potential indications in addition …